When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? 153
0 Visualizzazioni
• 07/10/23
0
0
Incorporare
administrator
Iscritti
Originally presented at the 23rd International Thyroid Cancer Survivors’ Virtual Conference held October 23-25, 2020.
When should one consider tyrosine kinase inhibitor therapy for medullary thyroid cancer? Robert F. Gagel, MD, Endocrinologist, and Mark E. Zafereo, MD, Head and Neck Surgeon.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti